CTLA4 and type 1 diabetes mellitus: CTLA4 is one of the components, and heterozygous deficiency of the protein gives rise to inappropriate polyclonal T-cell activation (10, 33, 34), leading to highly variable features of autoimmune responses, which may include endocrinopathies of adrenal insufficiency, T1DM, and thyroiditis (35).